Effects of all-trans retinoic acid and antireceptor antibodies on growth and programmed cell death of human myeloma cells

Clinical Cancer Research

Volumn 2, Issue 2, 1996, Pages 253-259

  Taetle, Raymond ^a,c   Dos Santos, Betty ^a   Akamatsu, Ken Ichi ^b   Koishihara, Yasuo ^b   Ohsugi, Yoshiyuki ^b  

^a UNIVERSITY OF ARIZONA   (United States)

^b CHUGAI PHARMACEUTICAL CO LTD   (Japan)

^c UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6 RECEPTOR; ISOTRETINOIN; RECEPTOR ANTIBODY; RETINOIC ACID; TRANSFERRIN RECEPTOR ANTIBODY; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MULTIPLE MYELOMA; PRIORITY JOURNAL;

ANTIBODIES, MONOCLONAL; APOPTOSIS; CELL DIVISION; HUMANS; MULTIPLE MYELOMA; RECEPTORS, INTERLEUKIN-6; RECEPTORS, TRANSFERRIN; TRETINOIN; TUMOR CELLS, CULTURED;

EID: 0029916895     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. LaCroix, A., and Lippman, M. E. Binding of retinoids to human breast cancer cell lines and their effects on cell growth. J. Clin. Invest., 65:586-591, 1980.
2. Lotan, R. Different susceptibilities of human melanoma and breast carcinoma cell lines to retinoic acid-induced growth inhibition. Cancer Res., 39: 1014-1019, 1979.
3. Su, I-J., Lay, Z-D., Cheng, A-L., and Chang, Y-C. Modulation of retinoic acid receptor alpha, growth factors and proto-oncogenes in retinoic acid-induced apoptosis of Ki-1 lymphoma cell line. Int. J. Oncol , 4: 1089-1095, 1994.
4. Trump, D. L. Retinoids in bladder, testis and prostate cancer: epidemiologic, pre-clinical and clinical observations. Leukemia (Baltimore), 8: S50-S54, 1994.
5. Frankel, S. R. Acute promyelocytic leukemia: new insights into diagnosis and therapy. Hematol Oncol. Clin. North Am., 7: 109-138, 1993.
6. Fenaux, P. Management of acute promyelocytic leukemia. Eur. J. Haematol., 50: 65-73, 1993.
7. Cheng, A-L., Su, I-J., Chen, C-C., Tien, H-F., Lay, J-D., Chen, B-R., Pu, Y-S., Hong, R-L., Shen. M-C., Wang, C-H., and Chen Y-C: Use of retinoic acids in the treatment of peripheral T-cell lymphoma: a pilot study. J. Clin. Oncol., 12: 1185-1192, 1994.
8. Knobler, R. M., Trautinger, F., Radaszkiewicz, T., Kokoschka, E. M., and Micksche, M. Treatment of cutaneous T cell lymphoma with a combination of low-dose interferon alfa-2b and retinoids. J. Am. Acad. Dermatol., 24: 247-252, 1991.
9. Zachariae, H., and Thestrup-Pedersen, K. Interferon alpha and etretinate combination treatment of cutaneous T-cell lymphoma. J. Invest. Dermatol., 95: 206S-208S, 1990.
10. Eisenhauer, E. A., Lippman, S. M., Kavanagh, J. J., Parades-Espinoza, M., Arnold, A., Hong, W. K., Massimini, G., Schleuniger, U., Bollag, W., Holdener, E. E., and Krakoff, I. Combination 13-cis-retinoic acid and interferon γ-2a in the therapy of solid tumors. Leukemia (Baltimore), 8: 1622-1625, 1994.
11. Sidell, N., Taga, T., Hirano, T., Kishimoto, T., and Saxon, A. Retinoic acid-induced growth inhibition of a human myeloma cell line via down-regulation of IL-6 receptors. J. Immunol., 146: 3809-3814, 1991
12. Levy, Y., Labaume, S., Gendron, M-C., and Brouet, J-C. Modulation of spontaneous B-cell differentiation in macroglobulinemia by retinoic acid. Blood. 83: 2206-2210, 1994.
13. Sun, I. L., Toole-Sims, W., Crane, F. L., Golub, E. S. , de Pagan, T. D., Morre, D. J., and Low, H. Retinoic acid inhibition of transplasmalemma diferric transferrin reductase. Biochem. Biophys. Res. Commun., 146: 976-982, 1987.
14. Taetle, R., Dos Santos, B., Ohsugi, Y., Koishihara, Y., Yamada, Y., Messner, H., and Dalton, W. S. Effects of combined anti-growth factor receptor treatment on in vitro growth of multiple myeloma. J. Natl. Cancer Inst., 86: 450-455, 1994.
15. Fisher, D. E. Apoptosis in cancer therapy: crossing the threshold. Cell, 78: 539-542, 1994.
16. Vaux, D. L., Haecker, G., and Strasser, A. An evolutionary perspective on apoptosis. Cell, 76: 777-779, 1994.
17. Williams, G. T., and Smith, C. A. Molecular regulation of apoptosis: genetic controls on cell death. Cell, 74: 777-779, 1993.
18. Steller, H. Mechanisms and genes of cellular suicide Science (Washington DC), 267: 1445-1456, 1995.
19. Thompson, C. B. Apoptosis in the pathogenesis and treatment of disease. Science (Washington DC), 207. 1456-1462, 1995.
20. Ponzoni, M., Bocca, P., Chiesa, V., Decensi, A., Pistoia, V., Raffaghello, L., Rozzo, C., and Montaldo, P. G. Differential effects of N-(4-hydroxyphenyl) retinamide and retinoic acid on neuroblastoma cells: apoptosis versus differentiation. Cancer Res., 55: 853-861, 1995.
21. Taetle, R., Payne, C., Dos Santox B , Russell, M., and Segarini, P. Effects of TGF-β1 on growth and apoptosis of human acute myelogenous leukemia cells. Cancer Res., 53: 3386-3393, 1993.
22. Taetle, R., Honeysett, J. M., and Houston, L. L. Effects of anti-epidermal growth factor (EGF) receptor antibodies and an anti-EGF receptor recombinant-ricin A chain immunoconjugate on growth of human cells. J. Natl. Cancer Inst., 80: 1053-1059, 1988.
23. Oval, J., and Taetle, R. Factor-dependent human leukemia cell lines: new models for regulation of acute non-lymphocvtic leukemia cell growth and differentiation. Blood Rev., 4: 270-279, 1990.
24. White, S., Taetle, R., Seligman, P. A., Rutherford, M., and Trowbridge, I. Combinations of antitransferrin receptor monoclonal antibodies inhibit human tumor cell growth in vitro and in vivo: evidence for synergistic antiproliferative effects. Cancer Res., 50: 6295-6301, 1990.
25. Adamson, P. C., Bailey, J., Pluda, J., Poplack, D. G., Bauza, S., Murphy, R. F., Yarchoan, R., and Balis, F. M. Pharmacokinetics of all-trans-retinoic acid administered on an intermittent schedule. J. Clin. Oncol., 13: 1238-1241, 1995.
26. Del Bino, G., Li, X., Traganos, F., and Darzynkiewicz, Z. Altered susceptibility of differentiating HL-60 cells to apoptosis induced by antitumor drugs. Leukemia (Baltimore), 8: 281-288, 1994.
27. Raza, A., Gezer, S., Mundle, S., Gao, X-Z, Alvi, S., Borok, R., Rifkin, S., Iftikhar, A., Shetty, V., Parcharidou, A., Loew, J., Marcus, B., Khan, Z., Chaney, C., Showel, J., Gregory, S., and Preisler, H. Apoptosis in bone marrow biopsy samples involving stromal and hematopoietic cells in 50 patients with myelodysplastic syndromes. Blood, 86: 268-276, 1995.
28. Divgi, C. R., Welt, S., Kris, M., Real, F. X., Yeh, S. D. J., Gralla, R., Merchant, B., Schweighart, S., Unger, M., Larson, S. M., and Mendelsohn, J. Phase I and imaging trial of indium 111-labeled anti-epidermal growth factor receptor monoclonal antibody 225 in patients with squamous cell lung carcinoma. J. Natl. Cancer Inst., 83: 97-104, 1991.
29. Brooks, D., Taylor, C., Dos Santos, B., Linden, H., Houghton, A., Hecht, T., Kornfeld, S., and Taetle, R. Phase 1a trial of naurine IgA antitransferin receptor antibody 42/6. Clin. Cancer Res., 1: 1259-1265, 1995.
30. Fry, D. W., Kraker, A. J., McMichael, A., Ambrose, L. A., Nelson, J. M., Leopold, W. R., Connors, R. W., and Bridges, A. J. A specific inhibitor of the epidermal growth factor receptor tyrosine kinase. Science (Washington DC), 205: 1093-1095, 1994.
31. Gibbs, J. B., and Oliff, A. Pharmaceutical research in molecular oncology. Cell, 79: 193-198, 1994.
32. Man, T. Solid tumours - chemoprevention with retinoids. Leukemia (Baltimore), 8: 1785-1790, 1994.
33. Lippman, S. M., Benner, S. E., and Hong, W. K. Cancer chemoprevention. J. Clin. Oncol., 12: 851-873, 1994.
34. Lee, J. S., Newman, R. A., Lippman, S. M., Huber, M. H., Minor, T., Raber, M. N., Krakoff, I. H., and Hong, W. K. Phase I evaluation of all-trans-retinoic acid in adults with solid tumors. J. Clin. Oncol., 11: 959-966, 1993.
35. Wärri, A. M., Riika, H., Huovinen, R. L., Laine, A. M., Martikainen, P. M., and Härkonen, P. L. Apoptosis in toremifene-induced growth inhibition of human breast cancer cells in vivo and in vitro. J. Natl. Cancer Inst., 85: 1412-1418, 1993.
36. Colombel, M., Olsson, C. A., Ng, P-Y., and Buttyan, R. Hormone-regulated apoptosis results from reentry of differentiated prostate cells onto a defective cell cycle. Cancer Res., 52: 4313-4319, 1992.
37. Ishiyama, T., Nakamura, S., Akimoto, Y., Koike, M., Tomoyasu, S., Tsuruoka, N., Murata, Y., Sato, T., Wakabayashi, Y., and Chiba, S. Immunodeficiency and IL-6 production by peripheral blood monocytes in multicentric Castleman's disease. Br. J. Haematol., 86: 483-489, 1994.
38. Lust, J. A. Role of cytokines in the pathogenesis of monoclonal gammopathies. Mayo Clin. Proc., 69: 691-697, 1994.
39. Kyle, R. A. "Benign" monoclonal gammopathy - after 20 to 35 years of follow-up. Mayo Clin. Proc., 68: 26-36, 1993.
40. Levy, Y., Fermand, J-P., Navarro, S., Schmitt, C., Vainchenker, W., Sehgmann, M., and Brouet, J-C. Interleukin 6 dependence of spontaneous in vitro differentiation of B cells from patients with IgM gammopathy. Proc. Natl. Acad. Sci. USA, 87: 3309-3313, 1990.